title: [Intensive care treatment before and after liver transplantation].
abstract: BACKGROUND
  Liver transplantation (LT) has become an established therapeutic option for patients with acute and chronic liver failure. Overall survival has dramatically increased over the last decades, mainly due to improved surgical techniques, the introduction of new immunosuppressive and anti-infective drugs but also due to continuous progress in the pre- and post-operative intensive care management of these patients.
  
  
  OBJECTIVE
  This article aims to give a short overview of the main aspects regarding pre- and post-LT critical care issues.
  
  
  RESULTS
  Intensive care treatment plays a major role in the management of patients with acute and acute-on-chronic liver failure in order to enable a life-saving LT for these patients. Severe infections/sepsis mostly accompanied by multi-organ failure represent the major challenges for intensive care specialists. The immediate postoperative care takes place in the intensive care unit (ICU) in almost all patients. The expected ICU stay has been significantly shortened over the years to an average of about 1-2 days. Infections as well as acute kidney injury are the main complications in the first post-operative weeks being responsible for prolonged ICU stays. Immunologic and surgical complications are additional important issues in the post-LT intensive care setting.
  
  
  CONCLUSIONS
  The intensive care management pre and post LT is an important, multidisciplinary challenge in the successful treatment of patients with acute and chronic liver failure.
authors.affiliation: Abteilung für Innere Medizin, Landeskrankenhaus Hall i.T., Milserstr. 10, 6060, Hall, Österreich, ivo.graziadei@tilak.at.
authors.forename: I
authors.initials: I
authors.lastname: Graziadei
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D003422:Critical Care / Q000379:methods*; D005858:Germany; D006084:Graft Rejection / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017093:Liver Failure / Q000401:mortality / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods* / Q000401:mortality; D009894:Opportunistic Infections / Q000401:mortality / Q000517:prevention & control; D011182:Postoperative Care / Q000379:methods*; D011300:Preoperative Care / Q000379:methods*; D015996:Survival Rate
chemical_list: D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents